Yale-New Haven Hospital has unveiled plans to build up its St. Raphael campus with a 505,000-square foot, $838 million neuroscience center for research and treatment of diseases like Parkinson’s, Alzheimer’s, epilepsy, multiple sclerosis, and strokes.
“This is very exciting news,” said Dawn Hocevar, President and CEO of BioCT. “Yale is the leader in neuroscience and the investment of $838 million is significant for patients, New Haven, and the growing bioscience Industry in the state of Connecticut. Thank you Yale!” more